A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural tumor

; pos: bottom-left">mesothelioma

ETOP BEAT-meso

Coordinating investigator

Dr. med.
Amina
Scherz
Inselspital Bern
+41 31 362 21 11

For further information on the trial please consult the ETOP website: www.etop-eu.org.

All trials